Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report
Orlandi, A, Fasciani, R, Cassano, A, Agresta, A, Calegari, M A, Caporossi, A, Barone, C
Published in BMC cancer (16.12.2015)
Published in BMC cancer (16.12.2015)
Get full text
Journal Article
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients
Basso, M, Strippoli, A, Orlandi, A, Martini, M, Calegari, M A, Schinzari, G, Di Salvatore, M, Cenci, T, Cassano, A, Larocca, L M, Barone, C
Published in British journal of cancer (15.01.2013)
Published in British journal of cancer (15.01.2013)
Get full text
Journal Article
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas
Orlandi, A, Di Salvatore, M, Bagalà, C, Basso, M, Strippoli, A, Plastino, F, Calegari, M A, Cassano, A, Astone, A, Barone, C
Published in Journal of Cancer (2015)
Published in Journal of Cancer (2015)
Get full text
Journal Article
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation
Calegari, M A, Inno, A, Monterisi, S, Orlandi, A, Santini, D, Basso, M, Cassano, A, Martini, M, Cenci, T, de Pascalis, I, Camarda, F, Barbaro, B, Larocca, L M, Gori, S, Tonini, G, Barone, C
Published in British journal of cancer (09.05.2017)
Published in British journal of cancer (09.05.2017)
Get full text
Journal Article
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse
Orlandi, A., Calegari, M. A., Martini, M., Cocomazzi, A., Bagalà, C., Indellicati, G., Zurlo, V., Basso, M., Cassano, A., Larocca, L. M., Barone, C.
Published in Clinical & translational oncology (01.10.2016)
Published in Clinical & translational oncology (01.10.2016)
Get full text
Journal Article
Chemotherapy Rechallenge or Reintroduction Compared to Regorafenib or Trifluridine/Tipiracil for Pretreated Metastatic Colorectal Cancer Patients: A Propensity Score Analysis of Treatment Beyond Second Line (Proserpyna Study)
Calegari, M.A., Zurlo, I.V., Dell'Aquila, E., Basso, M., Orlandi, A., Bensi, M., Camarda, F., Anghelone, A., Pozzo, C., Sperduti, I., Salvatore, L., Santini, D., Corsi, D.C., Bria, E., Tortora, G.
Published in Clinical colorectal cancer (12.06.2024)
Published in Clinical colorectal cancer (12.06.2024)
Get full text
Journal Article
Transdermal granisetron for the prevention of chemotherapy-induced nausea and vomiting in metastatic colorectal cancer patients with high risk of bowel obstruction treated with temozolomide
Calegari, M.A., Monterisi, S., Orlandi, A., Inno, A., Barile, R., Corallo, S., Di Dio, C., Zurlo, V., Basso, M., Cassano, A., Barone, C.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article